7th International Congress on Drug Therapy in HIV Infection (ICDTHI), 14-18 November 2004, Glasgow
29 March 2005. Related: Conference reports.
HIV 7th Glasgow 2004
Nandrolone decanoate combats HIV-related weight loss: results from three randomised studies
29 March 2005. Related: Conference reports, Coinfections and complications.
Atazanavir boosts intracellular saquinavir levels: data on important new dual-boosted regimen
29 March 2005. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Marked variability in plasma atazanavir levels: importance of ritonavir boosting and TDM
29 March 2005. Related: Conference reports, Antiretrovirals.
Effective switching to atazanavir/ritonavir in clinical practice
29 March 2005. Related: Conference reports, Antiretrovirals.
Ritonavir boosting may not overcome interaction between atazanavir and nevirapine
29 March 2005. Related: Conference reports, Antiretrovirals.
Nevirapine associated adverse events in a cohort of pregnant women
29 March 2005. Related: Conference reports, Pregnancy.
Higher nevirapine doses for children leads to better outcome
29 March 2005. Related: Conference reports, Paediatric care.
TDM in Ugandan study highlights importance of refridgerated ritonavir
29 March 2005. Related: Conference reports, Antiretrovirals.
Responses to TB treatment in HIV positive and HIV negative patients in the UK
29 March 2005. Related: Conference reports, TB coinfection.
800mg efavirenz may not be needed with rifampicin-based TB regimens, especially in African patients
29 March 2005. Related: Conference reports, TB coinfection.
EuroSIDA shows HIV-HCV coinfected patients more likely to stop HAART because of side effects
29 March 2005. Related: Conference reports, Side effects.
Lower d4T dose maintains virologic suppression and CD4 increases
29 March 2005. Related: Conference reports, Antiretrovirals.